Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04858490Completed
Open-label, single-arm trial of diazepam in alcohol withdrawal syndrome (AWS), sponsored by Center for Addiction and Mental Health. Primary endpoints: Retention in Treatment and Transfer to a Higher Level of Care. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04858490.